The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index; 20 of the 42 sources its claims cite were checked for support.
Sex differences in Alzheimer’s disease and common neuropathologies of aging
Open accessAbstract
Alzheimer’s dementia is significantly more common in women than in men. However, few pathological studies have addressed sex difference in Alzheimer’s disease (AD) and other brain pathologies. We leveraged postmortem data from 1453 persons who participated in one of two longitudinal community-based studies of older adults, the Religious Orders Study and the Rush Memory and Aging Project. Postmortem examination identified AD pathologies, neocortical Lewy bodies, DNA-binding protein 43 (TDP-43), hippocampal sclerosis, gross and micro infarcts, atherosclerosis, arteriolosclerosis, and cerebral amyloid angiopathy. Linear and logistic regressions examined the association of sex with each of the pathologic measures. Two-thirds of subjects were women (n = 971; 67%), with a mean age at death of 89.8 (SD = 6.6) years in women and 87.3 (SD = 6.6) in men. Adjusted for age and education, women had higher levels on a global measure of AD pathology (estimate = 0.102, SE = 0.022, p < 0.001), and tau tangle density in particular (estimate = 0.334, SE = 0.074, p < 0.001), and there was a borderline difference between women and men in amyloid-β load (estimate = 0.124, SE = 0.065, p = 0.056). In addition, compared to men, women were more likely to have more severe arteriolosclerosis (OR = 1.28, 95% CI:1.04–1.58, p = 0.018), and less likely to have gross infarcts (OR = 0.78, 95% CI:0.61–0.98, p = 0.037), although the association with gross infarct was attenuated after controlling for vascular risk factors. These data help elucidate the neuropathologic footprint of sex difference in AD and other common brain pathologies of aging.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
In 1,453 autopsies from two community-based aging cohorts, women had more Alzheimer’s disease (AD) pathology, especially tau tangle density, and more severe arteriolosclerosis than men. These differences were not explained by age, APOE ε4, menopause type, or hormone replacement therapy.
Key findings
- Among 1,453 deceased participants (971 women, 67%; mean age at death 89.8 years in women vs. 87.3 in men), women had higher global AD pathology after adjustment for age and education (estimate=0.102, SE=0.022, p<0.001) and higher tau tangle density (estimate=0.334, SE=0.074, p<0.001); Aβ load was borderline (estimate=0.124, SE=0.065, p=0.056).
- More than 60% met pathologic criteria for AD, with a higher percentage in women (68%) than men (58%); women were 35% more likely to have a pathologic AD diagnosis (OR=1.35, 95% CI:1.06–1.72).
- Women were more likely to have severe arteriolosclerosis (OR=1.28, 95% CI:1.04–1.58, p=0.018) and less likely to have gross infarcts (OR=0.78, 95% CI:0.61–0.98, p=0.037), though the gross infarct association attenuated after controlling for vascular risk factors (OR=0.80, 95% CI:0.63–1.02, p=0.072).
- No sex differences were found for neocortical Lewy bodies, TDP-43, hippocampal sclerosis, microinfarcts, atherosclerosis, or cerebral amyloid angiopathy; no interaction was found between sex and APOE ε4, and both natural- and surgical-menopause women had higher AD pathology than men.
Methods
- Cross-sectional postmortem analysis of 1,453 participants from the Religious Orders Study and Rush Memory and Aging Project, two longitudinal community-based cohorts of older adults without dementia at entry; follow-up exceeded 90% and autopsy rate exceeded 85%.
- Neuropathologic evaluation included immunohistochemistry and stereology for tau tangle density and Aβ load across 8 cortical regions, a global AD pathology score from Bielschowsky silver-stained neuritic plaques, diffuse plaques, and neurofibrillary tangles, plus assessments of Lewy bodies, TDP-43, hippocampal sclerosis, infarcts, atherosclerosis, arteriolosclerosis, and cerebral amyloid angiopathy.
- Linear and logistic regressions adjusted for age and education examined sex associations, with additional models for age and APOE ε4 interactions, menopause type/age, hormone replacement therapy, vascular risk factors, and cohort; analyses used SAS version 9.4.
Limitations
- The paper states participants had higher education levels and more than 95% were Caucasian, reducing generalizability; tau measures described only neuronal, not astrocytic, tau burden and lacked aging-related tau astrogliopathy data; contribution of primary age-related tauopathy or AD subtypes was unknown; only single-epitope fibrillary Aβ and helical filament tau were quantified; and autopsy was limited to one hemisphere.
- Evident from the text: the cross-sectional autopsy design cannot establish causality or temporal ordering, and the cohort composition may limit generalizability to more diverse or clinically referred populations.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
20 of 42 cited sources checked · 13 supported · 3 flagged · accuracy not yet measured
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Likewise, two studies that reported different sex-AD pathology association in different ages did not utilize statistical interaction modeling [34,43].”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > DISCUSSION:
What the sources say
- Supportedcites [34] Kovacs GG, Alafuzoff I, Al-Sarraj S, Arzberger T, Bogdanovic N, Capellari S et al (2008) Mixed brain pathologies in dementia: the BrainNet Europe consortium experience. Dement Geriatr Cogn Disord 26:343–350 source
The Influence of Age and Gender section reports that AD was more frequent in men under 75 but pure AD was more frequent in women over 75. The Statistical Analysis section describes comparisons by age and gender group, but no statistical interaction model for the sex–AD association. This verdict concerns the cited Kovacs study, not the other study in the citing sentence. (LLM, conf=0.88)
- Disputedcites [43] Nelson PT, Schmitt FA, Jicha GA, Kryscio RJ, Abner EL, Smith CD et al (2010) Association between male gender and cortical Lewy body pathology in large autopsy series. J Neurol 257:1875–1881 sourceExperimental — accuracy not yet measured
The Results (page not provided) report a different sex–AD pathology association before and after age 80, but they also state that an age-by-diagnosis interaction was assessed in a separate logistic model. That directly contradicts the claim that this study did not use statistical interaction modeling; the interaction was not significant. (LLM, conf=0.92)
Checked by a reasoning model — may be wrong.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“With uniform data collection, it is feasible to combine data across the two cohorts to examine associations of clinical data with brain pathologies, as done in many of our prior studies [4,45].”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > METHODS:
What the sources say
- Supportedcites [4] Arvanitakis Z, Capuano AW, Leurgans SE, Bennett DA, Schneider JA (2016) Relation of cerebral vessel disease to Alzheimer’s disease dementia and cognitive function in elderly people: a cross-sectional study. Lancet Neurol 15:934–943 source
The Methods, Subjects section identifies the Religious Orders Study and Rush Memory and Aging Project and says their essentially identical data-collection methods facilitate combining data to examine clinical and pathologic factors in the aging brain. This directly supports the attributed claim. (LLM, conf=0.95)
- Supportedcites [45] Oveisgharan S, Buchman AS, Yu L, Farfel J, Hachinski V, Gaiteri C et al (2018) APOE epsilon2epsilon4 genotype, incident AD and MCI, cognitive decline, and AD pathology in older adults. Neurology 92(24):e2127–e2134 source
The Methods (Participants; page not provided) explicitly state that uniform data collection and autopsy procedures allowed ROS and MAP data to be analyzed together. The Methods also describe clinical evaluations, postmortem pathology measurements, and analyses relating study data to AD pathology. (LLM, conf=0.94)
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Yet, clinical longitudinal studies have shown susceptibility of women with surgical menopause at young ages to cognitive decline [14] and dementia [52].”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > DISCUSSION:
What the sources say
- Supportedcites [14] Bove R, Secor E, Chibnik LB, Barnes LL, Schneider JA, Bennett DA et al (2014) Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology 82:222–229 source
This source is cited for cognitive decline [14], not for dementia [52]. Its Results report that earlier surgical menopause was associated with a steeper rate of cognitive decline in women from two longitudinal cohorts; it does not need to establish the separately cited dementia claim. (LLM, conf=0.94)
- Supportedcites [52] Rocca WA, Grossardt BR, Shuster LT, Stewart EA (2012) Hysterectomy, oophorectomy, estrogen, and the risk of dementia. Neurodegener Dis 10:175–178 source
The citation to this source is attached to the dementia portion of the sentence. In “The Mayo Clinic Cohort Study of Oophorectomy and Aging,” the paper reports increased risk of cognitive impairment or dementia after oophorectomy before natural menopause, with risk increasing at younger ages. Page numbers are not provided in our copy. (LLM, conf=0.92)
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In our previous study, we found that younger age at onset of menopause among women with surgical, not natural, menopause was associated with more AD pathologies [14].”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > DISCUSSION:
What the sources say
- Supportedcites [14] Bove R, Secor E, Chibnik LB, Barnes LL, Schneider JA, Bennett DA et al (2014) Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology 82:222–229 source
The Results section reports that earlier age at surgical menopause was associated with a higher global burden of AD neuropathology, particularly neuritic amyloid plaques. It also reports no association between age at natural menopause and any neuropathologic outcome. (LLM, conf=0.94)
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Few if any of the previous studies which investigated the association of sex with AD pathologies have examined menopausal factors [25,41,43,53].”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > DISCUSSION:
What the sources say
- Could not verifycites [25] Hohman TJ, Dumitrescu L, Barnes LL, Thambisetty M, Beecham G, Kunkle B et al (2018) Sex-specific association of apolipoprotein E With cerebrospinal fluid levels of Tau. JAMA Neurol 75(8):989–998 sourceExperimental — accuracy not yet measured
The Introduction describes prior research on sex differences in APOE-associated Alzheimer’s pathology, and the Discussion proposes hormonal changes around menopause as a possible mechanism. Neither passage says whether few, if any, previous studies examined menopausal factors. Searches for menopausal status and hormone measures did not establish that claim. (LLM, conf=0.72)
- Not checked — no full text of the sourcecites [41] Miller FD, Hicks SP, D’Amato CJ, Landis JR (1984) A descriptive study of neuritic plaques and neurofibrillary tangles in an autopsy population. AmJ Epidemiol 120:331–341 source
- Could not verifycites [43] Nelson PT, Schmitt FA, Jicha GA, Kryscio RJ, Abner EL, Smith CD et al (2010) Association between male gender and cortical Lewy body pathology in large autopsy series. J Neurol 257:1875–1881 sourceExperimental — accuracy not yet measured
The Introduction and Discussion discuss sex hormones as possible influences on neurodegenerative disease, but do not assess whether previous studies of sex and AD pathology examined menopausal factors. A search for menopause, postmenopausal status, and related factors found only a postmenopausal-estrogen study in the References, not a statement supporting the claimed assessment of prior studies. (LLM, conf=0.73)
- Not checked — no full text of the sourcecites [53] Sandberg G, Stewart W, Smialek J, Troncoso JC (2001) The prevalence of the neuropathological lesions of Alzheimer’s disease is independent of race and gender. Neurobiol Aging 22:169–175 source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“given the association of arteriolosclerosis with AD dementia [4].”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > DISCUSSION:
What the sources say
- Supportedcites [4] Arvanitakis Z, Capuano AW, Leurgans SE, Bennett DA, Schneider JA (2016) Relation of cerebral vessel disease to Alzheimer’s disease dementia and cognitive function in elderly people: a cross-sectional study. Lancet Neurol 15:934–943 source
The Results section (‘Vessel disease and odds of AD dementia’) reports that each increase in arteriolosclerosis severity was associated with significantly higher odds of AD dementia (OR 1.20, 95% CI 1.04–1.40). The Discussion likewise describes an independent association. (LLM, conf=0.95)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In animal experiments, bilaterally ovariectomized rats developed Aβ 1 −42 in the hippocampus after exposure to stress, a finding which corroborate with our finding of more Aβ in women with surgical menopause at young ages [59,66].”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > DISCUSSION:
What the sources say
- Partly supportedcites [59] Scott EL, Zhang QG, Vadlamudi RK, Brann DW (2014) Premature menopause and risk of neurological disease: basic mechanisms and clinical implications. Mol Cell Endocrinol 389:2–6 sourceExperimental — accuracy not yet measured
Section 3.1 reports increased hippocampal amyloidogenesis in surgically menopausal rats after ischemic stress. It separately says their hippocampus was more sensitive to the neurotoxic effects of Aβ1-42; it does not establish that the stress caused the rats to develop that specific peptide. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Supportedcites [66] Zhang QG, Wang RM, Scott E, Han D, Dong Y, Tu JY et al (2013) Hypersensitivity of the hippocampal CA3 region to stress-induced neurodegeneration and amyloidogenesis in a rat model of surgical menopause. Brain 136:1432–1445 source
The Methods section describes bilateral ovariectomy in female rats. The ‘Enhanced amyloidogenic processing’ section reports a robust rise in amyloid-β1-42 in the hippocampal CA3 region of long-term ovariectomized rats after ischaemic stress. The claim omits those specific conditions but accurately paraphrases the finding. (LLM, conf=0.93)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no interaction, suggesting that our finding of higher AD pathology in women compared to men did not vary by the APOE ε4 status.”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > RESULTS: > Effects of age and APOE ε4 on the relation of sex to AD
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When we added to the predictors a term for an interaction between sex and the categorical age we found the interaction to be non-significant (Table 3)”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > RESULTS: > Effects of age and APOE ε4 on the relation of sex to AD
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, compared to men, women were more likely to have more severe arteriolosclerosis (OR=1.28, 95% CI:1.04–1.58, p=0.018)”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > Abstract
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes
- Probably not a substantial claim. 24
- It may state two separate claims as one. 29
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“In this study, we used a 4-stages classification of TDP-43 distribution based on previous studies [30,42]”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > METHODS: > Pathologic evaluation
What the sources say
- Supportedcites [30] James BD, Wilson RS, Boyle PA, Trojanowski JQ, Bennett DA, Schneider JA (2016) TDP-43 stage, mixed pathologies, and clinical Alzheimer’s-type dementia. Brain 139:2983–2993 source
The Pathological TDP-43 inclusions section says the authors created stages of TDP-43 distribution guided by prior literature and observations in their cohort. The Discussion explicitly calls it a four-stage scheme, including the stage with no TDP-43, and relates its progression to previous staging research. (LLM, conf=0.93)
- Disputedcites [42] Nag S, Yu L, Capuano AW, Wilson RS, Leurgans SE, Bennett DA et al (2015) Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease. Ann Neurol 77:942–952 sourceExperimental — accuracy not yet measured
The Methods (Immunohistochemical studies) explicitly recognize three stages of TDP-43 distribution, not four. The paper says its assessment was described previously, but it does not support the attributed four-stage classification. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Yet, to date, only a few studies have directly investigated the association between sex and AD and other common neuropathologies. Further, these included only a small sample size (less than 200 brain autopsies) [41,53], or did not examine pathologies other than AD [41,43,53].”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > INTRODUCTION
What the sources say
- Not checked — no full text of the sourcecites [41] Miller FD, Hicks SP, D’Amato CJ, Landis JR (1984) A descriptive study of neuritic plaques and neurofibrillary tangles in an autopsy population. AmJ Epidemiol 120:331–341 source
- Not checked — no full text of the sourcecites [53] Sandberg G, Stewart W, Smialek J, Troncoso JC (2001) The prevalence of the neuropathological lesions of Alzheimer’s disease is independent of race and gender. Neurobiol Aging 22:169–175 source
- Disputedcites [43] Nelson PT, Schmitt FA, Jicha GA, Kryscio RJ, Abner EL, Smith CD et al (2010) Association between male gender and cortical Lewy body pathology in large autopsy series. J Neurol 257:1875–1881 sourceExperimental — accuracy not yet measured
The paper contradicts the characterization attributed to it. Its Abstract reports 3,830 autopsied subjects, and the Introduction says it tested associations between sex and AD, neocortical Lewy body, and mixed pathologies—not AD alone. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Further, another study reported that an AD pathologic diagnosis was more common among women in patients older than age 75 years [34].”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > INTRODUCTION
What the sources say
- Supportedcites [34] Kovacs GG, Alafuzoff I, Al-Sarraj S, Arzberger T, Bogdanovic N, Capellari S et al (2008) Mixed brain pathologies in dementia: the BrainNet Europe consortium experience. Dement Geriatr Cogn Disord 26:343–350 source
The “Influence of Age and Gender” section reports that among patients above 75, more women had pure AD. The Discussion likewise says the female predominance in neuropathologically diagnosed AD generally applied only above age 75. (LLM, conf=0.94)
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Common age-related neuropathologies, including Alzheimer’s disease (AD) and other neurodegenerative and cerebrovascular pathologies, are the main causes of dementia, including Alzheimer’s dementia [31,34].”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > INTRODUCTION
What the sources say
- Not checked — no full text of the sourcecites [31] Jellinger KA, Attems J (2015) Challenges of multimorbidity of the aging brain: a critical update. J Neural Transm (Vienna) 122:505–521 source
- Partly supportedcites [34] Kovacs GG, Alafuzoff I, Al-Sarraj S, Arzberger T, Bogdanovic N, Capellari S et al (2008) Mixed brain pathologies in dementia: the BrainNet Europe consortium experience. Dement Geriatr Cogn Disord 26:343–350 sourceExperimental — accuracy not yet measured
The Introduction says neurodegenerative diseases are the most common disorders underlying dementia, and the Results document AD, vascular pathology, and other diagnoses among people with dementia. The Influence of Age and Gender section reports that AD and combined diagnoses were more frequent in older patients. The paper does not establish that cerebrovascular pathology is among the main causes, or specifically assess the causes of clinically diagnosed Alzheimer’s dementia. (LLM, conf=0.83)
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In prior work, we found that women, a subset of those in the current study, who had surgical menopause at an early age had a faster decline in cognitive function and more AD pathology at autopsy, and neuritic plaques in particular, compared to women with surgical menopause at older ages [14].”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > INTRODUCTION
What the sources say
- Supportedcites [14] Bove R, Secor E, Chibnik LB, Barnes LL, Schneider JA, Bennett DA et al (2014) Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology 82:222–229 source
The Results section reports that younger age at surgical menopause was associated with faster global cognitive decline and a higher burden of AD neuropathology, with the strongest association among individual markers for neuritic amyloid plaques. The Neuropathologic measures section confirms that the pathology was assessed from brain autopsies. Page numbers were not supplied in our copy. (LLM, conf=0.94)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“One clinical-pathologic study reported that the odds of AD pathology was not different between women and men if they were younger than 80 years at death, but women older than 80 years had a higher odds of AD pathology compared to men [43].”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > INTRODUCTION
What the sources say
- Supportedcites [43] Nelson PT, Schmitt FA, Jicha GA, Kryscio RJ, Abner EL, Smith CD et al (2010) Association between male gender and cortical Lewy body pathology in large autopsy series. J Neurol 257:1875–1881 source
The Abstract reports higher odds of AD pathology in women who died after age 80 and says this tendency was not seen before age 80. The Results likewise report a female tendency after 80 but no gender-related effect before 80. (LLM, conf=0.94)
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“while vascular risk factors like higher blood pressure levels have been found associated with cerebral vessel disease including arteriolosclerosis [28,3]”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > DISCUSSION:
What the sources say
- Not checked — no full text of the sourcecites [28] Ighodaro ET, Abner EL, Fardo DW, Lin AL, Katsumata Y, Schmitt FA et al (2017) Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals. J Cereb Blood Flow Metab 37:201–216 source
- Supportedcites [3] Arvanitakis Z, Capuano AW, Lamar M, Shah RC, Barnes LL, Bennett DA et al (2018) Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology. Neurology. https://doi.org/10.1212/wnl.0000000000005951 source
In “Relation of BP to cerebrovascular disease pathology,” the paper reports that higher mean systolic blood pressure was associated with greater severity of both atherosclerosis and arteriolosclerosis. The Discussion likewise identifies these as large- and small-vessel pathologies. The association with arteriolosclerosis was specific to systolic, not diastolic, blood pressure. (LLM, conf=0.93)
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“More than 60% of all autopsied participants met criteria for a pathologic diagnosis of AD, and the percentage was higher among women (68%) than men (58%) (p<0.001).”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > RESULTS: > AD pathology
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, participants older than 90 were not different from participants aged 80–90 years (p = 0.238) although both groups had higher global AD pathologic scores than participants younger than 80 (both p < 0.001), indicating a non-linear relationship between age and AD pathology.”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > RESULTS: > Effects of age and APOE ε4 on the relation of sex to AD
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and less likely to have gross infarcts (OR=0.78, 95% CI:0.61–0.98, p=0.037), although the association with gross infarct was attenuated after controlling for vascular risk factors.”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Women had higher levels of tangles in both mesial temporal and neocortical regions, but had higher levels of amyloid only in the mesial temporal.”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > RESULTS: > AD pathology
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Women were about 3 years older than men (p<0.001), had one year less of education (p<0.001), and had fewer vascular risk factors (p<0.001).”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > RESULTS:
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“HRT was used by nearly 40% (n=397) of women in their life, was more frequently used by women with surgical than natural menopause (59% vs. 33%, p<0.001), and was in the oral dosing formulation in 93% of women.”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > RESULTS: > Effects of menopause and HRTon the relation of sex to AD
Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found that both women with natural and those with surgical menopause have higher levels of AD pathologies compared to men.”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > DISCUSSION:
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“About a third of women (n=306, 32%) reported having been exposed to surgical menopause, and menopause was induced by hysterectomy in 95% of cases.”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > RESULTS: > Effects of menopause and HRTon the relation of sex to AD
Strength:plain· not yet calibratedn = 306Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We did not observe any sex difference in the APOE ε4 status (p=0.844), Alzheimer’s dementia (p=0.099), or vascular diseases burden (p=0.633).”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > RESULTS:
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Compared to women with natural menopause, women with surgical menopause were younger at menopause (43.4±7.7 vs.48.8±5.5, p<0.001), as expected, but were not different at age of death (89.6±6.3 vs. 90.0±6.7, p=0.350) or years of education (15.7±3.4 vs. 15.9±3.3, p=0.458).”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > RESULTS: > Effects of menopause and HRTon the relation of sex to AD
Strength:plain· not yet calibratedn = 306Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Of 732 (93%) who had an autopsy”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > METHODS:
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The overall follow-up rate of both cohorts exceeds 90%, and the autopsy rate exceeds 85%.”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > METHODS:
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Also, in earlier work, we found that women had more AD pathology and neurofibrillary tangles in particular, but not neuritic or diffuse plaques, among 141 subjects who came to autopsy [8].”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > INTRODUCTION
What the sources say
- Not checked — no full text of the sourcecites [8] Barnes LL, Wilson RS, Bienias JL, Schneider JA, Evans DA, Bennett DA (2005) Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry 62:685–691 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
In the paper
“and another study reported that the association of APOE ε4 with neurofibrillary tangles was weaker in men than in women, while the association with senile plaques was significant in both sexes [24].”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > INTRODUCTION
What the sources say
- Not checked — no full text of the sourcecites [24] Ghebremedhin E, Schultz C, Thal DR, Rub U, Ohm TG, Braak E et al (2001) Gender and age modify the association between APOE and AD-related neuropathology. Neurology 56:1696–1701 source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“In our previous study, we showed that the regional standardized scores were highly correlated with the global AD pathology score (r range: 0.47–0.73, median r = 0.67) and the Chronbach α coefficient was 0.90, indicating high internal consistency and supporting use of the global AD pathology score [13].”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > METHODS: > Pathologic evaluation
What the sources say
- Not checked — no full text of the sourcecites [13] Bennett DA, Wilson RS, Schneider JA, Evans DA, Aggarwal NT, Arnold SE et al (2003) Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer’s disease. Neurology 60:246–252 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“One autopsy study found that women had more senile plaques, and the association was stronger among ε4 carriers [17]”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > INTRODUCTION
What the sources say
- Not checked — no full text of the sourcecites [17] Corder EH, Ghebremedhin E, Taylor MG, Thal DR, Ohm TG, Braak H (2004) The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism. Ann N Y Acad Sci 1019:24–28 source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“In this study, a dichotomous summary variable was used indicative of presence or absence of neocortical-type Lewy body pathology which we previously showed to be associated with dementia [57].”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > METHODS: > Pathologic evaluation
What the sources say
- Not checked — no full text of the sourcecites [57] Schneider JA, Arvanitakis Z, Yu L, Boyle PA, Leurgans SE, Bennett DA (2012) Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies. Brain 135:3005–3014 source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Of the estimated 5.2 million people with Alzheimer’s dementia in the United States, 3.3 million are women and 1.9 million are men [2].”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > INTRODUCTION
What the sources say
- Not checked — no full text of the sourcecites [2] Association Alzheimer’s (2016) 2016 Alzheimer’s disease facts and figures. Alzheimers Dement 12:459–509 source
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“In our previous paper, we showed these summary measures to be reliable and internally consistent [11]. The Chronbach α coefficient was 0.84 for the tangles densities and 0.88 for the Aβ loads, showing high item (regions’ measures) total (summary measures) correlations.”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > METHODS: > Pathologic evaluation
What the sources say
- Not checked — no full text of the sourcecites [11] Bennett DA, Schneider JA, Wilson RS, Bienias JL, Arnold SE (2004) Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol 61:378–384 source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“DNA genotyping was performed at Polymorphic DNA Technologies (Alameda, CA) by investigators blinded to all clinical and pathological data.”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > METHODS: > Apolipoprotein E determination
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“of whom 756 (83%) had an autopsy”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > METHODS:
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“In addition, a board-certified neuropathologist, blinded to clinical data, determined the pathologic diagnosis of AD based on published criteria [26].”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > METHODS: > Pathologic evaluation
What the sources say
- Not checked — no full text of the sourcecites [26] Hyman BT, Trojanowski JQ (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56:1095–1097 source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Core models were evaluated for violations of assumptions, by examining data both analytically and graphically.”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > METHODS: > Statistical analyses
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“We added terms for other common brain pathologies to the predictors of the core models, and the results did not change: women had more AD pathology, specifically more tau tangles density (Supplemental Table e-6).”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > RESULTS: > AD pathology
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Participants had higher levels of education and more than 95% were Caucasians, reducing generalizability to other populations.”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > DISCUSSION:
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“More advanced statistical methods and larger samples may explain the discrepant results among recent and prior studies.”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > DISCUSSION:
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Finally, the two studies have uniform and structured procedures, and neuropathological evaluations are conducted blinded to clinical data.”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > DISCUSSION:
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Also, we do not know how much of our tangle finding was driven by the primary age-related tauopathy (PART), or what subtypes of AD, i.e. tangle-predominant form of AD, account for most of the variance in the association of sex with the AD pathologic indices.”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > DISCUSSION:
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Although two other studies reported differential associations between APOE ε4 and AD pathological indices in women and men [17,24], they do not contain any formal interaction test between sex and APOE ε4.”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > DISCUSSION:
What the sources say
- Not checked — no full text of the sourcecites [17] Corder EH, Ghebremedhin E, Taylor MG, Thal DR, Ohm TG, Braak H (2004) The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism. Ann N Y Acad Sci 1019:24–28 source
- Not checked — no full text of the sourcecites [24] Ghebremedhin E, Schultz C, Thal DR, Rub U, Ohm TG, Braak E et al (2001) Gender and age modify the association between APOE and AD-related neuropathology. Neurology 56:1696–1701 source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Taken together, menopausal factors did not account for the higher AD pathology, and tau specifically, among women.”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > DISCUSSION:
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Our tau tangle density measure describes only neuronal, not astrocytic, tau tangle burden, and currently we do not have data on aging-related tau astriogliopathy (ARTAG).”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > DISCUSSION:
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Lastly, the autopsy procedures were carried out on only one hemisphere, and pathologies restricted to the other hemisphere may be missed.”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > DISCUSSION:
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Finally, the two studies have uniform and structured procedures, and neuropathological evaluations are conducted blinded to clinical data.”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > DISCUSSION:
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“It included about 1500 brain autopsies of participants in one of two community-based longitudinal studies of ageing, and with a large proportion of women allowing for comparison of women and men.”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > DISCUSSION:
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Furthermore, we only quantified the helical filament tau-positive tangles and the fibrillary form of Aβ by utilizing antibodies against single epitopes.”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > DISCUSSION:
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Furthermore, a recent meta-analysis of 58000 participants showed that APOE ε3/ε4 women have the same increased odds of AD dementia as APOE ε3ε4 men have, in contrast to a previous meta-analysis which reported APOE ε4 women to carry a higher risk of Alzheimer’s dementia compared to APOE ε4 men [21].”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > DISCUSSION:
What the sources say
- Not checked — no full text of the sourcecites [21] Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R et al (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta analysis consortium. JAMA 278:1349–1356 source
Strength:plain· not yet calibratedn = 58,000Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Our tau tangle density measure describes only neuronal, not astrocytic, tau tangle burden, and currently we do not have data on aging-related tau astriogliopathy (ARTAG).”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > DISCUSSION:
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Also, the cohort studies have more than 90% follow up and about 85% autopsy rates, decreasing several sources of bias, including selection bias due to attrition.”
§ Sex differences in Alzheimer’s disease and common neuropathologies of aging > DISCUSSION:
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, despite their prolonged survival, even with Alzheimer’s disease [7–9], women exhibit increased global Alzheimer’s neuropathological burden and greater cognitive impairment [10–13].”
From Age, sex and Alzheimer’s disease: a longitudinal study of 3xTg-AD mice reveals sex-specific disease trajectories and inflammatory responses mirrored in postmortem brains from Alzheimer’s patients (2024) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Moreover, post mortem studies indicate that females have lower resistance to AD pathologies. 70 , 71”
From Unraveling sex differences in Alzheimer's disease and related endophenotypes with brain proteomes (2025) · cites this paper as [70]
Citations
Cites
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Lee, J. A. H. (1986) · JAMA · doi:10.1001/jama.1986.03370120114036 · Cited by 2,252
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992
Self-citationHYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
Religious Orders Study and Rush Memory and Aging Project
Bennett, D. A., Buchman, A. S., Boyle, P. A., Barnes, L. L., Wilson, R. S., & Schneider, J. A. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179939 · Cited by 1,260
Self-citationClinical epidemiology of Alzheimer’s disease: assessing sex and gender differences
Mielke, M., Vemuri, P., & Rocca, W. (2014) · Clinical Epidemiology · doi:10.2147/clep.s37929 · Cited by 1,021
Age, Neuropathology, and Dementia
Savva, G. M., Wharton, S. B., Ince, P. G., Forster, G., Matthews, F. E., & Brayne, C. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806142 · Cited by 900
Individual differences in rates of change in cognitive abilities of older persons.
Wilson, R. S., Beckett, L. A., Barnes, L. L., Schneider, J. A., Bach, J., Evans, D. A., & Bennett, D. A. (2002) · Psychology and Aging · doi:10.1037/0882-7974.17.2.179 · Cited by 842
Self-citationRocca, W. A., Bower, J. H., Maraganore, D. M., Ahlskog, J. E., Grossardt, B. R., de Andrade, M., & Melton, L. J. (2007) · Neurology · doi:10.1212/01.wnl.0000276984.19542.e6 · Cited by 827
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 339
Plasma neurofilament light reflects more severe manifestation of Alzheimer’s disease in men
Cheng, X., Wang, Z., He, K., Xia, Y., Wang, Y., Guo, Q., Xie, F., & Yuan, P. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03149-z · Cited by 5
Cortical thickness reveals sex differences in verbal and visuospatial memory
Sang, F., Zhao, S., Li, Z.-L., Yang, Y., Chen, Y., & Zhang, Z. (2024) · Cerebral Cortex · doi:10.1093/cercor/bhae067 · Cited by 7
Shi, J. S. (2020) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2020.25.004160 · Cited by 6
Jia, Y., Du, X., Wang, Y., Song, Q., & He, L. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176485 · Cited by 5
Martínez-Drudis, L., Bérard, M., Musiol, D., Rivest, S., & Oueslati, A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39571 · Cited by 6
Quantifying natural amyloid plaque accumulation in the continuum of Alzheimer’s disease using ADNI
Elhefnawy, M. E., Patson, N., Mouksassi, S., Pillai, G. C., Shcherbinin, S., Chigutsa, E., & Gueorguieva, I. (2025) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-024-09959-y · Cited by 6
Kim, D.-Y., Kiss, A., Bronskill, S. E., Lanctôt, K. L., Herrmann, N., & Gallagher, D. (2022) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5809 · Cited by 5
da Silva, S. P., Castro, C. C. M., Rabelo, L. N., Engelberth, R. C. G. J., Fernández‐Calvo, B., & Fiuza, F. P. (2023) · GeroScience · doi:10.1007/s11357-023-00982-4 · Cited by 6
Morros-Serra, M., Melendo-Azuela, E. M., Garre‐Olmo, J., Garriga, O. T., & Santaeugènia, S. (2024) · Journal of Women & Aging · doi:10.1080/08952841.2024.2397158 · Cited by 4
Age and sex are associated with Alzheimer's disease neuropathology in Down syndrome
Andrews, E. J., Ngo, P. T., Pascual, J. R., Gonzalez, F., Phelan, M. J., Wright, S. T., Harp, J. P., Schmitt, F. A., Lai, F., Lao, P. J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70408 · Cited by 4
Sex Differences in the Preventive Effect of Cardiovascular and Metabolic Therapeutics on Dementia
Choi, S. A., Jee, H. J., Bormate, K. J., Kim, Y., & Jung, Y.-S. (2023) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2023.115 · Cited by 5
Oveisgharan, S., Grodstein, F., Evia, A. M., James, B. D., Capuano, A. W., Chen, Y., Arfanakis, K., Schneider, J. A., & Bennett, D. A. (2024) · Neurology · doi:10.1212/wnl.0000000000209172 · Cited by 4
Self-citationSex still matters for the brain and mental health across the lifespan
Beltz, A. M., Tronson, N. C., Singh, M., & Rezq, S. (2025) · Biology of Sex Differences · doi:10.1186/s13293-025-00710-x · Cited by 4
Pluta, R. M. (2025) · Life · doi:10.3390/life15071146 · Cited by 4
Neuroticism biases memory self-report in women
Bratlee‐Whitaker, E., Hill, N. L., Mogle, J. A., & Bhang, I. (2019) · Journal of Women & Aging · doi:10.1080/08952841.2019.1700729 · Cited by 4
Hirakawa, A., Sato, H., Hanazawa, R., Suzuki, K., & Initiative, J. A. D. N. (2022) · Statistics in Medicine · doi:10.1002/sim.9504 · Cited by 4
Dafnis, I., Mountaki, C., Fanarioti, Ε., Mastellos, D. C., Karvelas, M., Karathanos, V. Τ., Tzinia, A. K., Dermon, C. R., & Chroni, A. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03047-3 · Cited by 4
Gao, Z., Zhou, S., Zhu, W., Li, H., Huang, Z., Ji, Y., Li, X., & Yu, Y. (2022) · Neuroradiology · doi:10.1007/s00234-022-03099-1 · Cited by 4
Aberrant Cortical Activity in 5xFAD Mice in Response to Social and Non-Social Olfactory Stimuli
Kosel, F., Hartley, M. R., & Franklin, T. B. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230858 · Cited by 4
Mulero-Franco, J., Jimenez-Herrera, R., Contreras, A., Djebari, S., Jiménez-Díaz, L., & Navarro-López, J. D. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118247 · Cited by 4
Fueling Alzheimer’s Disease: Where Does Immunometabolism Stand?
Correia, S. C., Perry, G. L., & Moreira, P. I. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240787 · Cited by 3
Moallem, E. Z., Vekaria, H. J., Macheda, T., Hawkins, M. R., Roberts, K. N., Patel, S. P., Sullivan, P. G., & Bachstetter, A. D. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115629 · Cited by 3
Sundermann, E. E., Banks, S. J., Bondi, M. W., Martinez, M. A., Biegon, A. R., Rotblatt, L. J., & Hildebrandt, T. (2026) · Biology of Sex Differences · doi:10.1186/s13293-025-00820-6 · Cited by 3
Neuropathological correlates of age and sex differences in 18F-flortaucipir PET
Coomans, E. M., Smith, R. A., Pawlik, D., Hauer, K. O., Palmqvist, S., Stomrud, E., Mattsson, N., Tremblay, C., Serrano, G. E., Beach, T. G., et al. (2026) · Brain · doi:10.1093/brain/awag136 · Cited by 3
Unveiling FOXO3's metabolic contribution to menopause and Alzheimer's disease
O'Mahony, C., Hidalgo‐Lanussa, O., & Barreto, G. E. (2025) · Experimental Gerontology · doi:10.1016/j.exger.2025.112679 · Cited by 3
Oveisgharan, S., Yu, L., Yang, J., Agrawal, S., Vialle, R. A., Lopes, K. D. P., Tasaki, S., Wang, Y., Petyuk, V., Young‐Pearse, T. L., et al. (2025) · Neurology · doi:10.1212/wnl.0000000000214024 · Cited by 3
Self-citationBest practices for improving alignment and variant calling on human sex chromosomes
Oill, A. M. T., Plaisier, S. B., Phung, T. N., & Wilson, M. A. (2026) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2026.02.019 · Cited by 3
The Neurogenetics Collection: emerging themes and future considerations for the field in Brain
Traynor, B. J., & Al‐Chalabi, A. (2022) · Brain · doi:10.1093/brain/awac120 · Cited by 3
Brain Amyloid in Sporadic Young Onset Alzheimer’s Disease
Panegyres, P. K., & Robins, P. D. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220110 · Cited by 3
Lee, B. N., Wang, J., Hall, M. A., Kim, D., Stites, S. D., & Shen, L. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.10.002 · Cited by 3
Serum immunoglobulins and biomarkers of dementia: a population-based study
Yaqub, A., Khan, S. R., Vernooij, M. W., van Hagen, P. M., Peeters, R. P., Ikram, M. A., Chaker, L., & Dalm, V. A. S. H. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01333-3 · Cited by 4
G-protein coupled estrogen receptor 1, amyloid-β, and tau tangles in older adults
Oveisgharan, S., Yu, L., Lopes, K. D. P., Petyuk, V., Tasaki, S., Vialle, R. A., Menon, V., Wang, Y., Jager, P. L. D., Schneider, J. A., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06272-9 · Cited by 4
Self-citationMeng, W., Yang, Q., Xu, J., Huang, Y., Wang, C., Song, Q., Song, L., Bian, J., Ma, Q., Ma, A., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106391 · Cited by 3
“When sex influences the brain: implications for Alzheimer disease”
Frosch, M. P. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1931-y · Cited by 3
Sex-dependent polygenic effects on the clinical progressions of Alzheimer’s diseasePreprint
Fan, C. C., Banks, S. J., Thompson, W. K., Chen, C., McEvoy, L. K., Tan, C. H., Kukull, W. A., Bennett, D. A. A., Farrer, L. A., Mayeux, R. P., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/613893 · Cited by 3
Self-citationLopez-Lee, C., Kodama, L., Fan, L., Wong, M. Y., Foxe, N. R., Jiaz, L., Yu, F., Ye, P., Zhu, J., Norman, K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.19.558439 · Cited by 3
Interactive rather than independent effect of APOE and sex potentiates tau deposition in women
Wang, Y., Pascoal, T. A., Therriault, J., Kang, M.-S., Benedet, A. L., Savard, M., Tissot, C., Lussier, F. Z., Arias, J. F., Mathotaarachchi, S. S., et al. (2023) · doi:10.32920/24438049.v1 · Cited by 3
The Effect of the Tau Protein on D. melanogaster Lifespan Depends on GSK3 Expression and Sex
Veselkina, E. R., Trostnikov, M. V., Roshina, N. V., & PASYUKOVA, E. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032166 · Cited by 3
Esiaka, D. K., Strothkamp, S., Aghayeeabianeh, B., Broster, L. S., Powell, D. K., Jicha, G. A., & Jiang, Y. (2025) · Brain and Behavior · doi:10.1002/brb3.70912 · Cited by 2
Eissman, J. M., Qiao, M., Kalia, V., Zerlin, M., Reyes‐Dumeyer, D., Piriz, A. L., Dubey, S., Nandakumar, R., Lee, A., Lantigua, R., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70898 · Cited by 4
Lou, C., Wang, G., Xiong, Z., Jiang, Y. C., Li, Y., Zhu, M. Q., Yang, H., Wang, L., He, L., Chang, H., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102481 · Cited by 2
Wang, X., Ye, T., Dai, B., Zhang, J., Zhou, W., & Initiative, A. D. N. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877251406131 · Cited by 2
van Rooij, J. R. A., van den Berg, M., Vosselen, M. V., Calus, E., Vasilkovska, T., Kosten, L., Spilbeeck, I. V., Audekerke, J. V., Dam, D. V., Bertoglio, D., et al. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115647 · Cited by 2
Lanzillotta, S., Boccardi, V., Zulli, B., Napoli, A., Paolozzi, G., Angelini, R., Ruzicka, B., Fratini, F., Guazzarini, A. G., Scamosci, M., et al. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107291 · Cited by 2
Tau-PET and CSF MTBR-tau243 comparisons validate increased tau aggregation in females
Robinson, C. G., Binette, A. P., Horie, K., Sato, C., Schindler, S. E., Bateman, R. J., Benzinger, T. L. S., Janelidze, S., Singleton, E. H., Stomrud, E., et al. (2026) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-026-07934-y · Cited by 2
Impact of sex differences on microglial function in Alzheimer’s disease
Figueiredo, E. V., Azevedo, C. V., Penitente, A. R., Pedrosa, V. R., da Silva, V. R. C., & Longo, B. M. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02099-0 · Cited by 2
Navigating the Intersection of Sex, Vascular Risk Factors, and Cognitive Decline
Sur, N. B. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.100929 · Cited by 2
Conley, A. C., Vega, J. N., Johnson, J. V., Dumas, J. A., & NEWHOUSE, P. A. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1428675 · Cited by 2
Cui, C., Yu, T., Zhai, Y., Zhang, S., & Su, Z. (2024) · Medicine · doi:10.1097/md.0000000000039587 · Cited by 2
A multidomain trial for cognition in women with cardiovascular disease
Halloway, S., Schoeny, M. E., Arvanitakis, Z., Volgman, A. S., Pressler, S. J., Vispute, S., Wilhelm, K., Borgia, J. A., Wilbur, J., & Barnes, L. L. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70285 · Cited by 2
Self-citationBuckley, R. F., Scott, M. R., McGrath, E. R., Coughlan, G., Seto, M., Ghosh, S., Jacobs, H. I. L., Satizábal, C. L., Thibault, E. G., Vasan, R. S., et al. (2025) · Annals of Neurology · doi:10.1002/ana.27266 · Cited by 4
Sex differences in microglia as a risk factor for Alzheimer’s disease
Delage, C. I., Rendina, D. N., Malacon, K. E., Tremblay, M., & Bilbo, S. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819344-0.00008-9 · Cited by 2
Cai, Y., Fu, P., & Zhang, X. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137161 · Cited by 3
Amyloid beta oligomers modulate neuronal autophagy through the primary ciliumPreprint
Pampliega, O., Soria, F. N., Pineda-Ramírez, N., & Bézard, E. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.02.446758 · Cited by 2
Rodriguez, L. C., Noyes-Martel, N., Becker, J. D., Majewska, A. K., & O’Banion, M. K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.28.646050 · Cited by 3
Noto, N. M., Restrepo, Y. M., Hernandez, A., Vogel, C., Pulido-Correa, V., Moen, S., Bonetti, J., Chiduruppa, V., Speth, R. C., & Robison, L. S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.23.650226 · Cited by 2
Dai, P., Yu, J., Lin, Y., Zhou, X., Wang, H., Gong, W., Pan, J., Guan, Y., Zhong, J., Li, N., et al. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1584386 · Cited by 1
Halloy, N. R., Formanowicz, M., Pham, N. N. L., Hoyt, K. R., & Obrietan, K. H. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115458 · Cited by 1
Sex-specific brain atrophy patterns associated with the motoric cognitive risk syndrome
Blumen, H. M., Delpratt, N. A., Beauchet, O., Callisaya, M. L., Doi, T., Pradeep, V. G., Lipton, R. B., Milman, S., Shimada, H., Srikanth, V. K., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251378656 · Cited by 1
Relationship Between Neuropathology and Cognitive Impairment
Soares, F. B., Aliberti, M. J. R., Justo, A. F. O., Leite, R. E. P., Paes, V. R., Pasqualucci, C. A., Ferriolli, E., Grinberg, L. T., & Suemoto, C. K. (2025) · Neurology · doi:10.1212/wnl.0000000000214324 · Cited by 1
Schweitzer, N., Cover, C. G., Aizenstein, H. J., Wu, M., Vazquez, A. L., & Iordanova, B. E. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf472 · Cited by 1
Dhir, V., Sarmiento, I., McDonald, I., Gélinas-Faucher, M., Tremblay, S. A., Yaffe, M. J., Andersson, N., & Geddes, M. R. (2026) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2026.01.009 · Cited by 1
Zhang, B., Bian, W., Zhu, K., Dai, Y., Cai, M., Cheng, J., Chen, X., Xiang, Z., Liu, Y., & Lu, W. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05761-8 · Cited by 1
AI guided discovery of a murine model of asymptomatic Alzheimer’s disease
Jati, S., Taheri, S., Kal, S., Sinha, S. C., Head, B. P., Mahata, S. K., & Sahoo, D. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02286-y · Cited by 1
Tomash, A., Tazwar, M., Yasar, M. T., Zhang, S., Evia, A. M., Leurgans, S. E., Bennett, D. A., Schneider, J. A., & Arfanakis, K. (2026) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2026.05.007 · Cited by 1
Self-citationSchindler, E., & Reddy, P. H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15256-6.00001-5 · Cited by 1
Establishing cutoff values for visual amyloid positivity in [18F]flutemetamol PET
Park, Y.-J., Moon, S. Y., Yoon, J., Lee, S. J., & An, Y. (2025) · EJNMMI Research · doi:10.1186/s13550-024-01193-4 · Cited by 1
Arteriolosclerosis in CNS Tissues Outside the Cerebrum and Late-Life Motor Impairment
Oveisgharan, S., Agrawal, S., Yu, L., Leurgans, S. E., Hausdorff, J. M., Bennett, D. A., Schneider, J. A., & Buchman, A. S. (2025) · Stroke · doi:10.1161/strokeaha.124.050002 · Cited by 1
Self-citationSonsalla, M. M., Babygirija, R., Johnson, M., Cai, Y. S., Cole, M., Yeh, C., Grunow, I., Liu, Y., Vertein, D., Calubag, M. F., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.27.600472 · Cited by 1
Sex-Specific Differential DNA Methylation in Mild Cognitive Impairment and Alzheimer’s DiseasePreprint
Bergmann, P. E., Madrid, A., Papale, L. A., Clark, L. R., Asthana, S., Johnson, S. C., Keleş, S., Hogan, K. J., & Alisch, R. S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.15.654279 · Cited by 1
Dennison*, J. L., Miller*, M. A., Sharma, A., Cherry, A. M., Djuraskovic, I., Chapple, J. P., Timmons, J. A., Pitsillides, A. A., Wahlestedt, C., & Volmar, C. (2025) · Research Square · doi:10.21203/rs.3.rs-7769003/v1 · Cited by 1
Novozhilova, S., Fonov, V., Shafiee, N., et al. (2025) · medRxiv · doi:10.1101/2025.11.07.25339777 · Cited by 1
Sex Differences in the Associations between Education, Neuropathology, and CognitionPreprint
Raeesi, S., Zeighami, Y., Morrison, C., & Dadar, M. (2026) · medRxiv · doi:10.64898/2026.09.03.26362216 · Cited by 1
New Insights Into the APOE ε4–Soccer Heading Interaction
Banks, S. J., & Mez, J. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2019.4451
The Effects of Body Mass Index on Hippocampal Volume in Women with Down Syndrome
Kirsimagi, T. M. (2021) · ScholarWorks -A service of University of Vermont Libraries (University of Vermont)
Sex differences in neuroimaging biomarkers in healthy subjects and dementia
Massa, F., Arnaldi, D., Balma, M., Bauckneht, M., Chincarini, A., Ferraro, P. M., Grazzini, M., Lapucci, C., Meli, R., Morbelli, S. D., et al. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819344-0.00009-0
Schleicher, E. M. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8990
Cui, Y., Yang, W., Shuai, J., Ma, Y., & Yan, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1504550/v1
Clinical features and prognosis in Vascular Cognitive Impairment
Boomsma, J. M. F. (2023) · doi:10.5463/thesis.99
Is Vitamin D Supplementation a Danger to Potential Treatments of Alzheimer’s Disease Treatment?
Shih, P., Yong, S., Liu, C.-M., et al. (2023) · Current Alzheimer Research · doi:10.2174/1567205020666230530095421
Cognition Function and Dementia
Sundermann, E. E., Banks, S. J., & Menendez, C. E. E. A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780192864642.003.0010
Cui, C., Zhai, Y., Yu, T., Zhang, S., & Su, Z. (2023) · Research Square · doi:10.21203/rs.3.rs-3154959/v1
Interactive rather than independent effect of APOE and sex potentiates tau deposition in women
Wang, Y., Pascoal, T. A., Therriault, J., Kang, M.-S., Benedet, A. L., Savard, M., Tissot, C., Lussier, F. Z., Arias, J. F., Mathotaarachchi, S. S., et al. (2023) · doi:10.32920/24438049
Chow, H., Sun, J. K., Wu, D., Peng, A. Z., Wong, G. C., Hart, R. P., & Herrup, K. (2024) · Research Square · doi:10.21203/rs.3.rs-4489289/v1
Mulero‐Franco, J., Jiménez‐Herrera, R., Contreras, A., Djebari, S., Jiménez‐Díaz, L., & Navarro‐López, J. D. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.05.622060
Permutations of cerebrovascular pathologies in older adults with and without diabetes
Mehta, R. I., Capuano, A. W., Biswas, R., Bennett, D., & Arvanitakis, Z. (2025) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2025.100381 · Cited by 1
Self-citationKozyrev, N., Ibáñez, F. G., McKee, C., Traetta, M. E., Tellios, V., Nygard, K. L., Rylett, R. J., Tremblay, M., & Dekaban, G. A. (2025) · Research Square · doi:10.21203/rs.3.rs-6222217/v1
How and why your gender impacts your risk for dementia?
ZEIDAN, H. M., & ZEIDAN, I. H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21632-9.00004-2
Barrett-Young, A., Cawston, E. E., Ryan, B., Abraham, W. C., Ambler, A. P., Anderson, T., Cheyne, K. R., Goodin, E. A., Hogan, S., Houts, R., et al. (2025) · medRxiv · doi:10.1101/2025.04.09.25325556
Chesebro, A. G., Rohm, L. R., Antal, B. B., Weistuch, C., Strey, H. H., Ratai, E., Jones, D. T., & Mujica-Parodi, L. R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.14.648801
Eissman, J. M., Regelson, A. N., Walters, S., Archer, D. B., Durant, A., Mukherjee, S., Lee, M., Choi, S.-E., Scollard, P., Trittschuh, E., et al. (2025) · medRxiv · doi:10.1101/2025.05.26.25328369
Self-citationJati, S., Taheri, S., Kal, S., Sinha, S. C., Head, B. P., Mahata, S. K., & Sahoo, D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.11.659207
Sex Differences in Alzheimer Disease-Related Biomarkers and Dementia Risk
Toopchiani, S. T., Njogu, A. N., Smith, C., Sindi, S., Okoye, O., Watermeyer, T., & Udeh‐Momoh, C. T. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_19 · Cited by 1
Chen, X., Zhou, S., Wang, W., Gao, Z., Ye, W., Zhu, W., Lu, Y., Ma, J., Li, X., Yu, Y., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251364722
Chadha, S., Chase, J. L., Rosenblum, E. W., Smith, E. N., Mercaldo, N. D., Frosch, M. P., & Augustinack, J. C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.18.677182
Ranjan, R., Yusuf, M. A., Uddin, M., Mamun, M. T., Mamun, A. A., Kawnayn, G., & Hakim, M. (2025) · International Journal of General Medicine · doi:10.2147/ijgm.s559162
Filling in the gap: Hippocampal CA1 neuronal counts and volumes in female cognitive controls
Smith, E. N., Alexander, A. M., Watt, K. H., Rosenblum, E. W., Pihlstrom, N., Chase, J. L., Mercaldo, N. D., Conner, E., van der Kouwe, A. J. W., Frosch, M. P., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107161
takaliuang, D. S., Muljadi, R., Sutanto, R., & Situmeang, R. (2025) · Research Square · doi:10.21203/rs.3.rs-7953365/v1
Engel, M. G., Ayers, E. I., Adhikari, D., Stimmel, M. B., Weiss, E. F., Kumar, V. G. P., Sigamani, A., Verghese, J., & Ceïde, M. E. (2025) · Brain Sciences · doi:10.3390/brainsci15111204
Romero-Murillo, S., Lachén‐Montes, M., Cartas‐Cejudo, P., Anaya‐Cubero, E., de Miguel, M., Extramiana, L., Ferrer, I., Fernández‐Irigoyen, J., & Santamaría, E. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.26.690815
Metadata
- Authors
- Oveisgharan, S., Arvanitakis, Z., Yu, L., Farfel, J., Schneider, J. A., & Bennett, D. A.
- Affiliations
- Rush University Medical Center (US)
- Corresponding author
- Oveisgharan, Shahram
- Venue
- Acta Neuropathologica
- Published
- 2018-10-17
- Volume
- 136
- Issue
- 6
- Pages
- 887-900
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC6279593
- OpenAlex
- W2897712355
- Semantic Scholar
- 1ad7c3913ad11214ddf4ab763a09c0c3f7cd5c6f
- Cited by
- 330
- References
- 67
- Citations by year
- 2026: 37 · 2025: 69 · 2024: 43 · 2023: 47 · 2022: 44 · 2021: 42 · 2020: 23 · 2019: 23 · 2018: 2
- FWCI
- 15.57
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (submittedVersion)
- PubMed Central (submittedVersion)
- Funders
- National Institutes of Health (R01AG17917, P30AG10161, RO1NS084965, R01AG15819)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Sex and Gender in Healthcare
- Keywords
- Alzheimer's disease, sex differences, tau tangles, amyloid-beta, arteriolosclerosis, cerebral amyloid angiopathy, Lewy bodies, TDP-43, hippocampal sclerosis, cerebral infarction, atherosclerosis, postmortem brain examination, Religious Orders Study, Rush Memory and Aging Project
- MeSH terms
- Aged, Aged, 80 and over, Aging, Alzheimer Disease, Autopsy, Brain, Cross-Sectional Studies, DNA-Binding Proteins, Female, Humans, Longitudinal Studies, Male, Sex Characteristics, Chi-Square Distribution, tau Proteins, Arteriolosclerosis, alpha-Synuclein, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review